Novo Nordisk Financials

Novo Nordisk Stock Summary

Novo Nordisk competes with Sino Biopharmaceutica, Defence Therapeutics, Aileron Therapeutics, and Enlivex Therapeutics. Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. NOVO NORDISK is traded on OTC Exchange in the United States.

Novo Nordisk Key Financial Ratios

There are many critical financial ratios that Novo Nordisk's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Novo Nordisk AS reports annually and quarterly.

Novo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Novo Nordisk's current stock value. Our valuation model uses many indicators to compare Novo Nordisk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novo Nordisk competition to find correlations between indicators driving Novo Nordisk's intrinsic value. More Info.Novo Nordisk AS is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.30  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Novo Nordisk AS is roughly  3.32 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novo Nordisk's earnings, one of the primary drivers of an investment's value.

Novo Nordisk AS Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Novo Nordisk help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novo Nordisk AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novo Nordisk AS based on widely used predictive technical indicators. In general, we focus on analyzing Novo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novo Nordisk's daily price indicators and compare them against related drivers.

When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.